Antibiotic resistance - Running out of treatment options

Infection

Volumn 35, Issue 1, 2007, Pages 1-

  Ruef, C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CEPHALOSPORIN; CIPROFLOXACIN; COLISTIN; POLYMYXIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL INFECTION; EDITORIAL; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HUMAN; INDWELLING CATHETER; LUNG INFECTION; PROPHYLAXIS; UNSPECIFIED SIDE EFFECT;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; POLYMYXINS; RESPIRATORY TRACT INFECTIONS;

EID: 33847093300     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-007-7107-7     Document Type: Editorial

References (4)

1. Meyer E, Schwab F, Gastmeier P, Rueden H, Daschner FD: Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): A summary of the data from 2001 through 2004. Infection 2006; 34: 303-309.
2. Ye Y, Li JB, Ye DQ, Jiang ZJ: Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital. Infection 2006; 34: 252-257.
3. Henshke-Bar-Meir R, Yinnon AM, Rudensky B, Attias D, Schlesinger Y, Raveh D: Assessment of the clinical significance of production of extended-spectrum β-lactamases (ESBL) by Enterobacteriaceae. Infection 2006; 34: 66-74.
4. Falagas ME, Kasiakou SK: Local administration of polymyxins into the respiratory tract for the prevention and treatment of pulmonary infections in patients without cystic fibrosis. Infection 2007; 35: 3-10.